The interaction between the anticancer drug ellipticine and cytochromes P450 dictates its pharmacological efficiencies
2003
Abstract
Five metabolites containining an oxygene atom in their molecules are generated from ellipticine by CYPs. Ellipticine inhibits microsomal CYP-dependent activities and interacts with CYPs exhibiting a reverse type binding spectrum.